Skip to main content
. 2021 Jun 11;17(9):2348–2355. doi: 10.7150/ijbs.57810

Figure 4.

Figure 4

Effects of capivasertib on VSV-dG-Luc in Vero cells with SARS-CoV-2 spike overexpression or not. A. and B. Control vector pCAGGS (A) and the recombinant vector pCAGGS-HA-spike (B) were transfected into Vero cells for 24 h, respectively. Then, cells infected by VSV-dG-Luc at an MOI of 1 were incubated with different concentrations of capivasertib (0, 0.1 μM, 1 μM, and 10 μM), respectively. After 20 h, cells were collected and intracellular luciferase activity was analyzed by luciferase reporter assay.